PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 82 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,913,203 | +80.1% | 9,775,849 | 0.0% | 1.93% | +81.8% |
| Q2 2023 | $1,617,903 | -76.5% | 9,775,849 | +38.3% | 1.06% | -81.6% |
| Q1 2023 | $6,898,093 | +17.8% | 7,067,718 | +25.6% | 5.75% | +13.6% |
| Q4 2022 | $5,853,728 | +44.8% | 5,628,585 | +60.1% | 5.06% | +38.8% |
| Q3 2022 | $4,042,000 | -32.9% | 3,515,140 | +9.1% | 3.65% | -29.0% |
| Q2 2022 | $6,028,000 | +75.1% | 3,223,334 | +183.7% | 5.14% | +60.6% |
| Q1 2022 | $3,443,000 | +137.6% | 1,136,319 | +196.5% | 3.20% | +152.9% |
| Q4 2021 | $1,449,000 | – | 383,266 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |